Sachdev Thomas

机构：Kaiser Permanente Vallejo Medical Center · ORCID：0000-0003-3867-2454

发表论文 213 篇 · 总被引 1895 次 · h-index 21

代表论文

A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma (2026 · Blood · 被引 3)
Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. (2025 · Journal of Clinical Oncology · 被引 3)
Evaluation of a predictive biomarker for antibody drug conjugates (ADCs). (2024 · Journal of Clinical Oncology · 被引 3)
PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma (2024 · BJC Reports · 被引 3)
Development and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC). (2024 · Journal of Clinical Oncology · 被引 1)
Analysis of BRCA1/2 pathogenic variants, homologous recombination deficiency, and MYC amplification in the outcomes of advanced ovarian cancer. (2026 · Journal of Clinical Oncology)